Report
Alex Morozov
EUR 100.00 For Business Accounts Only

Becton, Dickinson Delivers Solid 4Q Results; 2019 Guidance Affected by Tariffs and Raw Materials

Becton, Dickinson reported strong fiscal fourth-quarter results, with revenue up 8.4% on a currency-neutral basis, ahead of our expectations. The company's 2019 guidance was slightly weaker than anticipated, however, which BD attributed largely to macro headwinds, including tariffs. We're likely to slightly raise our fair value estimate to account for cash flows realized since our last update; the shares appear fairly valued at current levels. Our narrow moat rating is unchanged.
All areas in t...
Underlying
Becton Dickinson and Company

Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The company's segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Alex Morozov

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch